Addex Therapeutics
ADXN
4 hedge funds and large institutions have $1.85K invested in Addex Therapeutics in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
20% less funds holding
Funds holding: 5 → 4 (-1)
46% less capital invested
Capital invested by funds: $3.46K → $1.85K (-$1.61K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$941 |
| 2 |
JP Morgan Chase
New York
|
-$699 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GI
1
GAMMA Investing
Foster City,
California
| $1.14K | – | – | – |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $655 | – | – | – |
|
|
SS
3
SBI Securities
Tokyo,
Japan
| $47 | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $9 | +$9 | +1 | New |
|
|
5
Morgan Stanley
New York
| – | -$941 | -100 | Closed |
|
|
6
JP Morgan Chase
New York
| – | -$699 | -79 | Closed |
|
ADXN Hedge Fund Activity: Q3 2025 in Review
4 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q3 2025, worth a combined $1.85K — down 46% from $3.46K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ADXN and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $9. The largest seller was Morgan Stanley, exiting entirely with an estimated $941 sold.
- 4 institutional investors held Addex Therapeutics (ADXN) as of Q3 2025, down from 5 in Q2 2025.
- Funds reported $1.85K of Addex Therapeutics stock for Q3 2025, down 46% quarter-over-quarter.
- 1 fund opened new Addex Therapeutics positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Addex Therapeutics buyer in Q3 2025 was UBS Group, an estimated $9 added.
- The largest Addex Therapeutics seller in Q3 2025 was Morgan Stanley, an estimated $941 sold.
Based on aggregated 13F filings for Q3 2025.